Carl-Gustav Olsson (Former)
1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Thromboprophylaxis with dalteparin in medical patients: which patients benefit?
(
- Contribution to journal › Article
- 2005
-
Mark
Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients - A subgroup analysis of the PREVENT Trial
(
- Contribution to journal › Article
-
Mark
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients
(
- Contribution to journal › Article
- 2004
-
Mark
Risk factors for venous thromboembolism in hospitalized patients with acute medical illness - Analysis of the MEDENOX study
(
- Contribution to journal › Article
-
Mark
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients
(
- Contribution to journal › Article
-
Mark
Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study
(
- Contribution to journal › Article
- 2003
-
Mark
Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study
(
- Contribution to journal › Article
- 2002
-
Mark
Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis
(
- Contribution to journal › Article
- 1979
-
Mark
Quality control of 99mTc-plasmin preparations for scintigraphic detection of deep venous thrombosis
(
- Contribution to journal › Published meeting abstract